THE global leader in  blood management solutions for our customers

2015 Press Releases

Webcast ImageWebcast
Q4 2015 Haemonetics Corporation Earnings Conference Call (Replay)
04/27/15 at 8:00 a.m. ET
Q4 2015 Haemonetics Corporation Earnings Conference Call
Monday, April 27, 2015 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Haemonetics Investor Day (Live)
05/19/15 at 10:00 a.m. ET
Haemonetics Investor Day
Tuesday, May 19, 2015 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
Apr. 27, 2015Haemonetics Expands Executive Management Roles To Complement Global Growth Strategy
BRAINTREE, Mass., April 27, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today expanded roles for two executives.  These changes are part of an ongoing plan to advance the Company's global leadership in blood management solutions and to execute on strategies to enhance shareholder value. Kent Davies, who joined the Company in 2014, is appointed to the new position of Chief Operating Officer, reporting directly to Brian Concannon, President and CEO.  In this expanded ro... 
Printer Friendly Version
Apr. 27, 2015Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; Provides Fiscal 2016 Guidance
BRAINTREE, Mass., April 27, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported revenue for the fourth quarter fiscal 2015 of $226.5 million, down 6%.  Excluding currency impact, revenue was down 4% in the quarter. The Company reported a fourth quarter GAAP net loss of $2.9 million or $0.06 per share.  Adjusted net income, exclusive of transformation, restructuring and deal amortization expenses detailed below, was $24.5 million, up 1%, and adjusted earnings per share were $0... 
Printer Friendly Version
Mar. 30, 2015Haemonetics Sets Date for Fourth Quarter and Full Fiscal Year 2015 Earnings Release: April 27, 2015
BRAINTREE, Mass., March 30, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) will announce its earnings for the fourth quarter and full fiscal year 2015 and will provide guidance for fiscal year 2016 on April 27, 2015 in a pre-market press release.  The Company will hold a webcast to discuss and answer questions about the press release at 8:00 am (EDT) on April 27, 2015. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=5188004 Web... 
Printer Friendly Version
Mar. 24, 2015Haemonetics Sets Date for Investor/Analyst Meeting - May 19, 2015
BRAINTREE, Mass., March 24, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Tuesday, May 19th from 9:00 am to 2:30 pm at The State Room, 60 State Street in Boston, Massachusetts. The agenda for the meeting includes updates on the following: Current Growth Drivers: Plasma/TEG®/Emerging Markets Future Growth Drivers: BloodTrack® HaemoBank™/Integrated Software Solutions/Device Connectivity R&D Up... 
Printer Friendly Version
Mar. 05, 2015Haemonetics and CSL Plasma Announce a Long-Term Plasma Collection Software Agreement
BRAINTREE, Mass. and BOCA RATON, Fla., March 5, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) and CSL Plasma, Inc. announced today that CSL Plasma, Inc. has selected Haemonetics' Next Generation Donor Management System ("NextGen DMS"), an innovative software application for the management of plasma collection, as its future system for managing more than 100 plasma donation centers across the U.S. and Europe.  The two companies completed a significant long-term technology agr... 
Printer Friendly Version
Feb. 25, 2015Haemonetics to Present at the Raymond James 36th Annual Institutional Investors Conference
BRAINTREE, Mass., Feb. 25, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the Raymond James 36th Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 3, 2015 at 2:50 pm Eastern time.  The public may access Mr. Concannon's presentation live via webcast at http://wsw.com/webcast/rj95/hae Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood man... 
Printer Friendly Version
Jan. 29, 2015Haemonetics Reports 3rd Quarter Fiscal 2015 Revenue of $232 Million and Adjusted EPS of $0.53; Reaffirms Revenue and EPS Guidance
BRAINTREE, Mass., Jan. 29, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported third quarter fiscal 2015 revenue of $231.8 million, down 4.3%.  In constant currency, revenue declined 1.4% in the quarter.  The Company reported third quarter GAAP net income of $16.0 million and GAAP net income per share of $0.31.  Exclusive of transformation, restructuring and deal amortization expenses detailed below, adjusted net income was $27.5 million and adjusted earnings per share were $... 
Printer Friendly Version
Jan. 26, 2015Due To Winter Storm, Haemonetics Moves Announcement of Third Quarter Fiscal 2015 Earnings Results To Thursday, January 29
BRAINTREE, Mass., Jan. 26, 2015 /PRNewswire/ -- Considering the impact of the severe winter storm expected this week on the East Coast, Haemonetics Corporation (NYSE: HAE) will delay by one day the release of its third quarter fiscal 2015 earnings results until 8:00am Thursday, January 29. The press release will also be available on the Company's website at www.haemonetics.com. Conference Call Haemonetics will host a webcast to discuss the third quarter and first nine months of fiscal 2015... 
Printer Friendly Version